These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chemotherapy, immunity and microbiota--a new triumvirate? Karin M; Jobin C; Balkwill F Nat Med; 2014 Feb; 20(2):126-7. PubMed ID: 24504404 [TBL] [Abstract][Full Text] [Related]
4. Gut microbiota: Anti-cancer therapies affected by gut microbiota. Greenhill C Nat Rev Gastroenterol Hepatol; 2014 Jan; 11(1):1. PubMed ID: 24322902 [No Abstract] [Full Text] [Related]
5. Biomedicine. Cancer therapies use a little help from microbial friends. Pennisi E Science; 2013 Nov; 342(6161):921. PubMed ID: 24264971 [No Abstract] [Full Text] [Related]
9. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Iida N; Dzutsev A; Stewart CA; Smith L; Bouladoux N; Weingarten RA; Molina DA; Salcedo R; Back T; Cramer S; Dai RM; Kiu H; Cardone M; Naik S; Patri AK; Wang E; Marincola FM; Frank KM; Belkaid Y; Trinchieri G; Goldszmid RS Science; 2013 Nov; 342(6161):967-70. PubMed ID: 24264989 [TBL] [Abstract][Full Text] [Related]
10. From promotion to management: the wide impact of bacteria on cancer and its treatment. Perez-Chanona E; Jobin C Bioessays; 2014 Jul; 36(7):658-64. PubMed ID: 24752750 [TBL] [Abstract][Full Text] [Related]
11. [The intestinal microbiota: a boost for antitumor treatments]. Sarukhan A Med Sci (Paris); 2014 Apr; 30(4):436-8. PubMed ID: 24801040 [TBL] [Abstract][Full Text] [Related]
12. Cyclophosphamide and cancer: golden anniversary. Emadi A; Jones RJ; Brodsky RA Nat Rev Clin Oncol; 2009 Nov; 6(11):638-47. PubMed ID: 19786984 [TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive drugs. I. Br Med J; 1970 Dec; 4(5736):663-5. PubMed ID: 4922755 [No Abstract] [Full Text] [Related]
14. Role of cyclosporin A in bacterial translocation. Montero EF; Silva RM; Keller R; Neto AB; Pessuto JM; Kim HC; Goldenberg S; Koh IH Transplant Proc; 1996 Oct; 28(5):2676. PubMed ID: 8908009 [No Abstract] [Full Text] [Related]
15. Chemotherapeutic suppression of immune enhancement: a primary determinant of successful cancer therapy. Mott MG Lancet; 1973 May; 1(7812):1092-4. PubMed ID: 4122012 [No Abstract] [Full Text] [Related]
16. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. Yang L; Li A; Lei Q; Zhang Y J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797 [TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy. Hanoteau A; Newton JM; Krupar R; Huang C; Liu HC; Gaspero A; Gartrell RD; Saenger YM; Hart TD; Santegoets SJ; Laoui D; Spanos C; Parikh F; Jayaraman P; Zhang B; Van der Burg SH; Van Ginderachter JA; Melief CJM; Sikora AG J Immunother Cancer; 2019 Jan; 7(1):10. PubMed ID: 30646957 [TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of so-called solid tumors]. Cappelaere P Sem Hop; 1971 Oct; 47(37):2203-6. PubMed ID: 4107784 [No Abstract] [Full Text] [Related]
19. Development of systemic bacteraemia after oral inoculation of vancomycin-resistant enterococci in mice. Miyazaki S; Fujikawa T; Kobayashi I; Matsumoto T; Tateda K; Yamaguchi K J Med Microbiol; 2001 Aug; 50(8):695-701. PubMed ID: 11478673 [TBL] [Abstract][Full Text] [Related]
20. Recent advances in cancer immunology and immunology-based anticancer therapies. Kumar S; Saini RV; Mahindroo N Biomed Pharmacother; 2017 Dec; 96():1491-1500. PubMed ID: 29198747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]